• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞病患者的股骨头坏死:加利福尼亚州的患病率、合并症及手术结果

Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.

作者信息

Adesina Oyebimpe, Brunson Ann, Keegan Theresa H M, Wun Ted

机构信息

Division of Hematology, Stanford University School of Medicine, Stanford, CA; and.

Center for Oncology Hematology Outcomes Research and Training, Division of Hematology Oncology, University of California Davis School of Medicine, Sacramento, CA.

出版信息

Blood Adv. 2017 Jul 11;1(16):1287-1295. doi: 10.1182/bloodadvances.2017005256.

DOI:10.1182/bloodadvances.2017005256
PMID:29296770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5728545/
Abstract

Osteonecrosis of the femoral head (ONFH) is a prevalent complication of sickle cell disease (SCD) that has not been well described in population-based cohort studies. Using California's Office of Statewide Planning and Development discharge databases (1991-2013), we estimated the cumulative incidence of ONFH after accounting for the competing risk of death and used a multivariable Cox proportional hazards regression to identify factors associated with ONFH diagnosis. We also calculated rates of readmissions to the hospital or emergency department within 30 to 90 days of hip replacement surgery. Of the 6237 patients in our SCD cohort, 22% (n = 1356) developed ONFH at a median age of 27 years, and 23% (n = 308) of the patients with ONFH underwent hip replacement surgery at a median age of 36 years. The cumulative incidence of ONFH to age 30 years was higher among SCD patients with more severe disease (24%; vs 8% in less severe) and those with antecedent acute chest syndrome (ACS) (18%; vs 8% without prior history of ACS). From 2003 to 2013, SCD patients with more severe disease (hazard ratio [HR], 2.77; 95% confidence interval [CI], 2.38-3.23) or with antecedent ACS (HR, 1.61; CI, 1.35-1.91) were more likely to develop ONFH. Twenty-seven percent of post-hip surgery patients were readmitted within 30 days, mostly for painful vaso-occlusive crises. ONFH is a common SCD complication that increases with age; ongoing studies into prevention and effective nonsurgical interventions for SCD-induced osteonecrosis must remain a high research priority.

摘要

股骨头坏死(ONFH)是镰状细胞病(SCD)的一种常见并发症,在基于人群的队列研究中尚未得到充分描述。利用加利福尼亚州全州规划与发展办公室的出院数据库(1991 - 2013年),我们在考虑死亡竞争风险后估计了ONFH的累积发病率,并使用多变量Cox比例风险回归来确定与ONFH诊断相关的因素。我们还计算了髋关节置换手术后30至90天内再次入院或前往急诊科的比率。在我们的SCD队列中的6237名患者中,22%(n = 1356)在中位年龄27岁时发生了ONFH,其中23%(n = 308)的ONFH患者在中位年龄36岁时接受了髋关节置换手术。在病情更严重的SCD患者(24%;病情较轻者为8%)和有既往急性胸部综合征(ACS)的患者(18%;无ACS病史者为8%)中,到30岁时ONFH的累积发病率更高。从2003年到2013年,病情更严重的SCD患者(风险比[HR],2.77;95%置信区间[CI],2.38 - 3.23)或有既往ACS的患者(HR,1.61;CI,1.35 - 1.91)更有可能发生ONFH。27%的髋关节置换术后患者在30天内再次入院,主要是因为疼痛性血管闭塞危象。ONFH是一种常见的SCD并发症,其发病率随年龄增长而增加;针对SCD引起的骨坏死的预防和有效的非手术干预的持续研究必须仍然是一个高度优先的研究事项。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0224/5728545/dddb01c0b091/advances005256absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0224/5728545/dddb01c0b091/advances005256absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0224/5728545/dddb01c0b091/advances005256absf1.jpg

相似文献

1
Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.镰状细胞病患者的股骨头坏死:加利福尼亚州的患病率、合并症及手术结果
Blood Adv. 2017 Jul 11;1(16):1287-1295. doi: 10.1182/bloodadvances.2017005256.
2
Epidemiology, Management, and Systematic Review of Surgical Trends for Patients Who Have Osteonecrosis of the Femoral Head.股骨头坏死患者手术趋势的流行病学、管理及系统评价
J Arthroplasty. 2025 Jun 7. doi: 10.1016/j.arth.2025.06.002.
3
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
4
Preoperative blood transfusions for sickle cell disease.镰状细胞病的术前输血
Cochrane Database Syst Rev. 2016 Apr 6;4(4):CD003149. doi: 10.1002/14651858.CD003149.pub3.
5
Are There Differences in Performance Among Femoral Stem Brands Utilized in Cementless Hemiarthroplasty for Treatment of Geriatric Femoral Neck Fractures?在用于治疗老年股骨颈骨折的非骨水泥半髋关节置换术中,不同品牌的股骨柄在性能上是否存在差异?
Clin Orthop Relat Res. 2025 Feb 1;483(2):253-264. doi: 10.1097/CORR.0000000000003222. Epub 2024 Aug 15.
6
Surgical Hip Dislocation in the Era of Hip Arthroscopy Demonstrates High Survivorship and Improvements in Patient-reported Outcomes for Complex Femoroacetabular Impingement.关节镜时代的髋关节脱位手术具有高存活率,并改善了复杂型股骨髋臼撞击症患者的报告结局。
Clin Orthop Relat Res. 2024 Sep 1;482(9):1671-1682. doi: 10.1097/CORR.0000000000003032. Epub 2024 Mar 21.
7
Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis.择期髋关节或膝关节手术患者预防出血的药物干预措施:系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2024 Jan 16;1(1):CD013295. doi: 10.1002/14651858.CD013295.pub2.
8
Hospital Readmissions Among People With Sickle Cell Disease.镰状细胞病患者的医院再入院情况。
JAMA Netw Open. 2025 Jun 2;8(6):e2517974. doi: 10.1001/jamanetworkopen.2025.17974.
9
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD012380. doi: 10.1002/14651858.CD012380.pub2.
10
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.

引用本文的文献

1
"I had to take a 'dead year' to undergo surgeries," the Lived Experiences of University Students with Sickle Cell Disease, an interpretative phenomenological analysis.“我不得不度过‘停滞的一年’来接受手术,”这是对患有镰状细胞病的大学生的生活经历进行的一项解释现象学分析。
Res Sq. 2025 Aug 26:rs.3.rs-7300043. doi: 10.21203/rs.3.rs-7300043/v1.
2
Osteoarticular Complications of Sickle Cell Disease in Bukavu: A Retrospective Multicenter Cross-Sectional Study.布卡武镰状细胞病的骨关节并发症:一项回顾性多中心横断面研究
Health Sci Rep. 2025 May 26;8(5):e70861. doi: 10.1002/hsr2.70861. eCollection 2025 May.
3
Risk Factors Associated With Osteonecrosis of the Femoral Head in Patients With Sickle Cell Disease: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.镰状细胞病患者静脉血栓栓塞症发病率增加:危险因素、复发情况及对死亡率的影响。
Br J Haematol. 2017 Jul;178(2):319-326. doi: 10.1111/bjh.14655. Epub 2017 Apr 3.
2
Symptomatic Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization by Patients with SCD.症状性缺血性坏死:镰状细胞病患者急性护理利用的一个研究不足的风险因素。
South Med J. 2016 Sep;109(9):519-24. doi: 10.14423/SMJ.0000000000000512.
3
Survival in adults with sickle cell disease in a high-income setting.
镰状细胞病患者股骨头坏死的相关危险因素:一项系统评价和荟萃分析
Cureus. 2025 Jan 1;17(1):e76734. doi: 10.7759/cureus.76734. eCollection 2025 Jan.
4
Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis.阿仑膦酸盐可维持患有镰状细胞病和骨质疏松症的成年人的骨矿物质密度。
Osteoporos Int. 2025 Jan;36(1):93-102. doi: 10.1007/s00198-024-07268-1. Epub 2024 Oct 22.
5
Long-term outcomes of avascular necrosis in sickle cell disease using joint-specific patient-reported outcome measures: Results from a multicentre study.使用特定关节患者报告结局指标评估镰状细胞病中无血管性坏死的长期结局:一项多中心研究的结果
Br J Haematol. 2025 Jan;206(1):310-319. doi: 10.1111/bjh.19802. Epub 2024 Sep 30.
6
Core Decompression with Bone Marrow Aspirate Concentrate Implantation in Osteonecrosis of the Femoral Head with a Minimum of 2-year Follow-up - A Pilot Study.带骨髓抽吸浓缩物植入的股骨头坏死核心减压术并至少随访2年——一项初步研究
J Orthop Case Rep. 2024 Aug;14(8):192-199. doi: 10.13107/jocr.2024.v14.i08.4696.
7
Total Hip Arthroplasty Complications in Sickle Cell Disease: Systematic Review and Meta-Analysis.镰状细胞病全髋关节置换术并发症:系统评价与荟萃分析
J Clin Med. 2024 Jul 15;13(14):4129. doi: 10.3390/jcm13144129.
8
A bone to pick-cellular and molecular mechanisms of bone pain in sickle cell disease.棘手问题——镰状细胞病骨痛的细胞和分子机制
Front Pain Res (Lausanne). 2024 Jan 4;4:1302014. doi: 10.3389/fpain.2023.1302014. eCollection 2023.
9
Clinical and epidemiological features and therapeutic options of avascular necrosis in patients with sickle cell disease (SCD): a cross-sectional study.镰状细胞病(SCD)患者的缺血性坏死的临床和流行病学特征及治疗选择:一项横断面研究。
Acta Biomed. 2023 Oct 17;94(5):e2023198. doi: 10.23750/abm.v94i5.14603.
10
Incidence and risk factors for osteonecrosis of the femoral head in five hundred and ten sickle cell disease paediatric patients.511 例镰状细胞病儿科患者中股骨头坏死的发生率及危险因素。
Int Orthop. 2023 Dec;47(12):2941-2952. doi: 10.1007/s00264-023-05886-8. Epub 2023 Jul 15.
高收入环境下镰状细胞病成人患者的生存情况。
Blood. 2016 Sep 8;128(10):1436-8. doi: 10.1182/blood-2016-05-716910. Epub 2016 Jul 20.
4
Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008.利用基于人群的监测系统定义镰状细胞病死亡率,2004年至2008年
Public Health Rep. 2016 Mar-Apr;131(2):367-75. doi: 10.1177/003335491613100221.
5
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.羟基脲与慢性输血用于维持镰状细胞贫血患儿经颅多普勒血流速度的比较——输血转换为羟基脲的经颅多普勒研究(TWiTCH):一项多中心、开放标签、3期、非劣效性试验。
Lancet. 2016 Feb 13;387(10019):661-670. doi: 10.1016/S0140-6736(15)01041-7. Epub 2015 Dec 6.
6
Avascular necrosis of left Hip joint secondary to sickle cell anaemia for hip arthroplasty.镰状细胞贫血继发左髋关节缺血性坏死,拟行髋关节置换术。
Indian J Anaesth. 2015 Oct;59(10):682-3. doi: 10.4103/0019-5049.167490.
7
Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease.缺氧再灌注影响成骨谱系并促进镰状细胞骨病。
Blood. 2015 Nov 12;126(20):2320-8. doi: 10.1182/blood-2015-04-641969. Epub 2015 Sep 1.
8
Comparison of US and Canadian Perioperative Outcomes and Hospital Efficiency After Total Hip and Knee Arthroplasty.美国和加拿大全髋关节和膝关节置换术后围手术期结局和医院效率比较。
JAMA Surg. 2015 Oct;150(10):990-8. doi: 10.1001/jamasurg.2015.1239.
9
Evidence for using alendronate to treat adult avascular necrosis of the femoral head: a systematic review.使用阿仑膦酸盐治疗成人股骨头缺血性坏死的证据:一项系统评价。
Med Sci Monit. 2014 Nov 26;20:2439-47. doi: 10.12659/MSM.891123.
10
Public health surveillance of nonmalignant blood disorders.非恶性血液疾病的公共卫生监测。
Am J Prev Med. 2014 Nov;47(5):664-8. doi: 10.1016/j.amepre.2014.07.025. Epub 2014 Sep 19.